Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06390904 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

Name: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients — clinical trial record (NCT06390904)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 2/3

SponsorXiaojun Chen

Started2022-07-13

View on ClinicalTrials.gov ↗

To investigate the efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) plus letrozole in obese progestin-insensitive atypical endometrial hyperplasia (EAH) patients.

Amendment record

Amended 2 times since 2024-04-25; most recent filed 2025-08-06. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2025-08-06

Amendment Recruiting→Active, Not Recruiting Study Status, Oversight, Contacts/Locations, IPDSharing v2

2024-07-31

Amendment Study Status, Contacts/Locations v1

2024-04-25

Original filing

Trial Details

NCT Number	NCT06390904
Lead Sponsor	Xiaojun Chen
Conditions	Atypical Endometrial Hyperplasia, Progesterone Resistance, Obesity
Enrollment	29 participants
Start Date	2022-07-13
Primary Completion	2025-07-30 (estimated)
Study Completion	2027-07-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-11